A Complement-Related Gene Signature for Predicting Overall Survival and Immunotherapy Efficacy in Sarcoma Patients

The prognoses of sarcomas are poor and the responses of them to systemic therapies are limited and controversial. Thus, there is an urgent need to stratify the risk factors and identify the patients who may benefit from systemic therapies. Here, we developed a reliable, complement-based gene signatu...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Lin, Lin, Weihao, Zhou, Yang, Shao, Fei, Gao, Yibo, He, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046668/
https://www.ncbi.nlm.nih.gov/pubmed/35493104
http://dx.doi.org/10.3389/fcell.2022.765062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046668/
https://www.ncbi.nlm.nih.gov/pubmed/35493104
http://dx.doi.org/10.3389/fcell.2022.765062

Ejemplares similares